Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Ingenus Pharmaceuticals, LLC

NDC labeler code: 50742

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

134Products (NDC)

Prescription medicines

Show the other 16 medicines

FDA applications for these products

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
ApprovedApplicationMedicineSponsor
October 16, 2026ANDA219588 Progesterone
PROGESTERONE
Novast Labs
October 15, 2025ANDA214023 Estrogens, conjugated
CONJUGATED ESTROGENS
Novast Labs
October 15, 2025ANDA214025 Estrogens, conjugated
CONJUGATED ESTROGENS
Novast Labs
July 9, 2025ANDA219569 Dehydrated alcohol
DEHYDRATED ALCOHOL
Ingenus Pharms LLC
July 2, 2025ANDA218032 Diltiazem
DILTIAZEM HYDROCHLORIDE
Novast Labs
March 17, 2025NDA218647 Chlorthalidone
HEMICLOR
Prm Pharma
January 13, 2025ANDA218871 Mesna
MESNA
Ingenus Pharms LLC
December 3, 2024ANDA217462 Colestipol hydrochloride
COLESTIPOL HYDROCHLORIDE
Riconpharma LLC
November 22, 2024ANDA215796 Oxcarbazepine
OXCARBAZEPINE
Riconpharma LLC
November 18, 2024ANDA218156 Arformoterol tartrate
ARFORMOTEROL TARTRATE
Lexenpharm
October 22, 2024ANDA216426 Formoterol fumarate
FORMOTEROL FUMARATE
Lexenpharm
August 22, 2024ANDA218410 Mesalamine
MESALAMINE
Novast Labs
May 3, 2024ANDA215571 Albuterol sulfate
ALBUTEROL SULFATE
Lexenpharm
April 5, 2024ANDA218002 Tafluprost
TAFLUPROST
Ingenus Pharms LLC
July 3, 2023ANDA217511 Bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride
BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
Ingenus Pharms LLC
May 1, 2023ANDA217260 Dorzolamide hydrochloride and timolol maleate
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
Ingenus Pharms LLC
February 13, 2023ANDA211591 Gefitinib
GEFITINIB
Qilu Pharm Hainan
December 2, 2022ANDA216404 Carbamazepine
CARBAMAZEPINE
Ingenus Pharms LLC
October 24, 2022ANDA215616 Metolazone
METOLAZONE
Renata
September 23, 2022ANDA216275 Diclofenac
DICLOFENAC SODIUM
Ingenus Pharms LLC
September 13, 2022ANDA216533 Timolol
TIMOLOL MALEATE
Ingenus Pharms LLC
June 16, 2022ANDA207802 Flunisolide
FLUNISOLIDE
Riconpharma LLC
June 2, 2022ANDA212756 Buprenorphine and naloxone
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Difgen Pharms
April 6, 2022ANDA213891 Frovatriptan succinate
FROVATRIPTAN SUCCINATE
Renata
April 6, 2022ANDA215586 Hydralazine hydrochloride and isosorbide dinitrate
ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE
Ingenus Pharms LLC
Show the other 35 applications
ApprovedApplicationMedicineSponsor
February 3, 2022ANDA213444 Pramipexole dihydrochloride
PRAMIPEXOLE DIHYDROCHLORIDE
Novast Labs
December 30, 2021ANDA214051 Ivabradine
IVABRADINE HYDROCHLORIDE
Ingenus Pharms LLC
October 8, 2021ANDA215585 Diclofenac
DICLOFENAC POTASSIUM
Ingenus Pharms LLC
September 23, 2021ANDA210272 Buprenorphine
BUPRENORPHINE
Difgen Pharms
January 25, 2021ANDA214352 Mexiletine hydrochloride
MEXILETINE HYDROCHLORIDE
Ingenus Pharms LLC
November 27, 2020ANDA210068 Methenamine hippurate
METHENAMINE HIPPURATE
Ingenus Pharms LLC
November 24, 2020ANDA212342 Scopolamine
SCOPOLAMINE
Riconpharma LLC
October 22, 2020ANDA091692 Levonorgestrel and ethinyl estradiol
DOLISHALE
Novast Labs
October 20, 2020ANDA214219 Triazolam
TRIAZOLAM
Ingenus Pharms LLC
July 30, 2020ANDA211132 Leucovorin calcium
LEUCOVORIN CALCIUM
Ingenus Pharms LLC
June 14, 2019ANDA208783 Diltiazem
DILTIAZEM HYDROCHLORIDE
Novast Labs
April 3, 2019ANDA210612 Estradiol and norethindrone acetate
ESTRADIOL AND NORETHINDRONE ACETATE
Novast Labs
March 12, 2019ANDA210267 Tizanidine
TIZANIDINE HYDROCHLORIDE
Ingenus Pharms LLC
March 12, 2019ANDA210614 Nifedipine
NIFEDIPINE
Novast Labs
March 5, 2019ANDA209675 Clonidine
CLONIDINE HYDROCHLORIDE
Novast Labs
November 15, 2018ANDA209315 Arsenic trioxide
ARSENIC TRIOXIDE
Ingenus Pharms LLC
November 5, 2018ANDA206490 Norethindrone acetate
NORETHINDRONE ACETATE
Ingenus Pharms LLC
November 5, 2018ANDA210918 Isosorbide mononitrate
ISOSORBIDE MONONITRATE
Riconpharma LLC
November 2, 2018ANDA209674 Metformin hydrochloride
METFORMIN HYDROCHLORIDE
Novast Labs
August 7, 2018ANDA208937 Tolcapone
TOLCAPONE
Ingenus Pharms LLC
August 1, 2018ANDA204735 Cabergoline
CABERGOLINE
Ingenus Pharms LLC
February 6, 2018ANDA204106 Metoprolol
METOPROLOL SUCCINATE
Novast Labs
December 26, 2017ANDA204963 Desipramine hydrochloride
DESIPRAMINE HYDROCHLORIDE
Ingenus Pharms LLC
November 29, 2017ANDA208947 Quetiapine
QUETIAPINE FUMARATE
Novast Labs
November 21, 2016ANDA206974 Lamivudine
LAMIVUDINE
Somerset Theraps LLC
September 30, 2016ANDA203434 Acetazolamide
ACETAZOLAMIDE
Novast Labs
August 25, 2016ANDA202987 Nifedipine
NIFEDIPINE
Novast Labs
June 23, 2016ANDA206043 Primaquine phosphate
PRIMAQUINE PHOSPHATE
Ingenus Pharms LLC
September 23, 2015ANDA205087 Cyproheptadine
CYPROHEPTADINE HYDROCHLORIDE
Ingenus Pharms LLC
July 22, 2015ANDA204372 Quinine sulfate
QUININE SULFATE
Ingenus Pharms LLC
October 22, 2008ANDA040823 Carisoprodol
CARISOPRODOL
Ingenus Pharms LLC
October 20, 2008ANDA077449 Fentanyl
FENTANYL-100, FENTANYL-12, FENTANYL-25
Difgen Pharms
May 13, 2008ANDA040618 Probenecid and colchicine
PROBENECID AND COLCHICINE
Ingenus Pharms LLC
June 1, 2006NDA021959 Prednisolone
ORAPRED ODT
Advanz Pharma
December 10, 1985NDA020145 Nitroglycerin
NITRO-DUR
Uspharma

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2022

  1. September 30, 2022 · Class II · Completed · D-0010-2023 · Flunisolide

    Out of specification for related substances (impurities).

    Flunisolide Nasal Solution, USP 0.025%, 25 mL bottles, Rx only, Manufactured for: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408; NDC 50742-317-25 UPC 3 50742 31725 7

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026

FDA Enforcement Report search → · Report an error →